Dashboard
1
The company has declared Negative results for the last 6 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 2,608.1 MM
- NET PROFIT(9M) At CNY 1,141.6 MM has Grown at -32.93%
- ROCE(HY) Lowest at 6.58%
Stock DNA
Pharmaceuticals & Biotechnology
CNY 54,705 Million (Large Cap)
34.00
NA
1.27%
-0.19
6.79%
2.22
Revenue and Profits:
Net Sales:
4,579 Million
(Quarterly Results - Jun 2026)
Net Profit:
954 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.6%
0%
14.6%
6 Months
22.2%
0%
22.2%
1 Year
12.63%
0%
12.63%
2 Years
55.96%
0%
55.96%
3 Years
49.57%
0%
49.57%
4 Years
110.11%
0%
110.11%
5 Years
130.77%
0%
130.77%
Sichuan Kelun Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.48%
EBIT Growth (5y)
4.76%
EBIT to Interest (avg)
12.24
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.74
Tax Ratio
20.20%
Dividend Payout Ratio
55.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.45%
ROE (avg)
10.61%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
2.31
EV to EBIT
32.20
EV to EBITDA
19.40
EV to Capital Employed
2.62
EV to Sales
2.84
PEG Ratio
NA
Dividend Yield
1.22%
ROCE (Latest)
8.14%
ROE (Latest)
6.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
4,579.30
4,693.40
-2.43%
Operating Profit (PBDIT) excl Other Income
777.70
894.50
-13.06%
Interest
24.70
27.20
-9.19%
Exceptional Items
11.20
7.50
49.33%
Consolidate Net Profit
953.60
454.30
109.91%
Operating Profit Margin (Excl OI)
89.10%
115.40%
-2.63%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is -2.43% vs -16.30% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 109.91% vs -51.15% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
18,350.10
21,619.40
-15.12%
Operating Profit (PBDIT) excl Other Income
3,433.70
5,141.30
-33.21%
Interest
107.40
154.70
-30.58%
Exceptional Items
49.90
-24.50
303.67%
Consolidate Net Profit
1,877.20
3,362.00
-44.16%
Operating Profit Margin (Excl OI)
109.70%
177.80%
-6.81%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -15.12% vs 1.69% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -44.16% vs 27.03% in Dec 2024
About Sichuan Kelun Pharmaceutical Co., Ltd. 
Sichuan Kelun Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






